patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991. J. Neurosurg., 88: 1–10, 1998.
2. Reports from the front. Science (Washington DC), 267: 1414, 1995.
3. Debinski, W., Obiri, N. I., Powers, S. K., Pastan, I., and Puri, R. K.
Human glioma cells over-express receptor for interleukin 13 and are
extremely sensitive to a novel chimeric protein composed of interleukin
13 and Pseudomonas exotoxin. Clin. Cancer Res., 1: 1253–1258, 1995.
4. Debinski, W., Miner, R., Leland, P., Obiri, N. I., and Puri, R. K.
Receptor for IL13 does not interact with IL4 but receptor for IL4
interacts with IL13 on human glioma cells. J. Biol. Chem., 271: 22428 –
22433, 1996.
5. McKenzie, A. N. J., Culpepper, J. A., De Waal Malefyt, R., Briere,
F., Punnonen, J., Aversa, G., Sato, A., Dang, W., Cocks, B. G., Menon,
S., De Vries, J. E., Banchereau, J., and Zurawski, G. Interleukin 13, a
T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA, 90: 3735–3739, 1993.
6. Minty, A., Chalon, P., Derocq, J. M, Dumont, X, Guillemot, J. C.,
Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., Minty, C.,
Casellas, P., Loison, G., Lupker, J., Shire, D., Ferrara, P., and Caput, D.
Interleukin-13 is a new human lymphokine regulating inflammatory and
immune responses. Nature (Lond.), 362: 248 –251, 1993.
7. Debinski, W., Obiri, N. I., Pastan, I., and Puri, R. K. A novel
chimeric protein composed of interleukin 13 and Pseudomonas exotoxin
is highly cytotoxic to human carcinoma cells expressing receptors for
interleukin 13 and interleukin 4. J. Biol. Chem., 270: 16775–16780,
1995.
8. Murata, T., Obiri, N. I., Debinski, W., and Puri, R. K. Structure of
IL-13 receptor: analysis of subunit composition in cancer and immune
cells. Biochem. Biophys. Res. Commun., 238: 92–94, 1997.
9. Obiri, N. I., Leland, P., Murata, T., Debinski, W., and Puri, R. K. The
IL-13 receptor structure differs on various cell types and may share
more than one component with IL-4 receptor. J. Immunol., 158: 756 –
764, 1997.
10. Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., and
Pastan, I. Immunotoxins that target an oncogenic mutant epidermal
growth factor receptor expressed in human tumors. Clin. Cancer Res., 1:
859 – 864, 1995.
11. Zellner, A., Fetell, M. R., Bruce, J. N., De Vivo, D. C., and
O'Driscoll, K. R. Disparity in expression of protein kinase C α in human
glioma versus glioma-derived primary cell lines: therapeutic implications. Clin. Cancer Res., 4: 1797–1802, 1998.
